Achieving Value through Health: Latest Evidence on Pharmacogenomics

Pharmacogenomics (PGx) is a core element of precision medicine, reducing the likelihood of adverse drug reactions and optimizing therapeutic efficacy. We will review and discuss the latest evidence on improving outcomes and affordability for certain PGx treatments in areas such as mental health and cancer.

SUGGESTED PRE-READING:

• New Research Finds Precision Medicine has reached a Global Tipping Point for Adoption
• Maturing Pharmacogenomic Factors Deliver Improvements and Cost Efficiencies”